Fox Run Management, L.L.C. Gilead Sciences, Inc. Transaction History

Fox Run Management, L.L.C.

$433 Million
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$71.58 - $87.29 $501,060 - $611,030	7,000 New	7,000 $512,000
Q3 2022 Nov 07, 2022	BUY	$59.54 - $68.01 $612,249 - $699,346	10,283 New	10,283 $634,000
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $551,918 - $621,625	-9,562 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$57.92 - $72.58 $238,109 - $298,376	4,111 Added 75.42%	9,562 $568,000
Q4 2021 Feb 09, 2022	BUY	$64.88 - $73.64 $353,660 - $401,411	5,451 New	5,451 $396,000
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $448,649 - $484,042	-6,628 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$63.47 - $69.35 $202,659 - $221,434	3,193 Added 92.95%	6,628 $456,000
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $206,100 - $235,160	3,435 New	3,435 $222,000
Q2 2020 Jul 31, 2020	SELL	$72.34 - $84.0 $307,445 - $357,000	-4,250 Closed	0 $0
Q1 2020 May 08, 2020	SELL	$62.63 - $80.22 $190,207 - $243,628	-3,037 Reduced 41.68%	4,250 $318,000
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $231,506 - $254,649	3,757 Added 106.43%	7,287 $474,000
Q2 2019 Jul 17, 2019	SELL	$61.87 - $69.38 $95,465 - $107,053	-1,543 Reduced 30.42%	3,530 $238,000
Q1 2019 Oct 17, 2019	SELL	$62.53 - $70.05 $338,725 - $379,460	-5,417 Reduced 51.64%	5,073 $330,000
Q4 2018 Jan 15, 2019	BUY	$60.54 - $79.0 $352,584 - $460,096	5,824 Added 124.82%	10,490 $656,000
Q3 2018 Oct 05, 2018	BUY	$71.28 - $78.92 $332,592 - $368,240	4,666 New	4,666 $360,000
Q1 2018 Apr 17, 2018	SELL	$72.84 - $88.8 $1.26 Million - $1.54 Million	-17,343 Closed	0 $0
Q4 2017 Jan 18, 2018	BUY	$71.15 - $83.52 $1.23 Million - $1.45 Million	17,343	17,343 $1.24 Million

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$10.8 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.4 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.88 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.55 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.41 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Fox Run Management, L.L.C. with notifications on news.

Account